Toward a Unifying Account of Dopamine's Role in Cost-Benefit Decision Making.

Delay discounting Dopamine Effort discounting Psychopharmacology Reward Risky decision making

Journal

Biological psychiatry global open science
ISSN: 2667-1743
Titre abrégé: Biol Psychiatry Glob Open Sci
Pays: United States
ID NLM: 9918227369306676

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 07 01 2022
revised: 25 02 2022
accepted: 25 02 2022
medline: 8 3 2022
pubmed: 8 3 2022
entrez: 1 5 2023
Statut: epublish

Résumé

Dopamine is thought to play a crucial role in cost-benefit decision making, but so far there is no consensus on the precise role of dopamine in decision making. Here, we review the literature on dopaminergic manipulations of cost-benefit decision making in humans and evaluate how well different theoretical accounts explain the existing body of evidence. Reduced D

Identifiants

pubmed: 37124350
doi: 10.1016/j.bpsgos.2022.02.010
pii: S2667-1743(22)00025-8
pmc: PMC10140448
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

179-186

Informations de copyright

© 2022 The Authors.

Références

Psychopharmacology (Berl). 2000 Sep;152(1):67-73
pubmed: 11041317
Psychopharmacology (Berl). 2007 Apr;191(3):461-82
pubmed: 17225164
J Neurosci. 2011 Nov 16;31(46):16597-602
pubmed: 22090487
Neuropharmacology. 2010 Jun;58(7):951-61
pubmed: 20096294
JAMA Psychiatry. 2019 Nov 1;76(11):1176-1186
pubmed: 31461131
Neuropsychopharmacology. 2020 Aug;45(9):1448-1453
pubmed: 32268344
J Comp Neurol. 2005 Dec 5;493(1):140-6
pubmed: 16254988
Exp Clin Psychopharmacol. 2007 Dec;15(6):599-609
pubmed: 18179313
Nat Hum Behav. 2019 Apr;3(4):383-392
pubmed: 30971787
J Child Psychol Psychiatry. 2014 Dec;55(12):1336-44
pubmed: 24798140
Nat Neurosci. 2011 Sep 25;14(11):1462-7
pubmed: 21946325
J Neurosci. 2013 Aug 7;33(32):12982-6
pubmed: 23926253
Neuropsychopharmacology. 2011 Jan;36(2):402-10
pubmed: 20980990
J Pharmacol Exp Ther. 1997 Jan;280(1):83-97
pubmed: 8996185
Science. 2010 Jul 30;329(5991):532
pubmed: 20671181
Front Integr Neurosci. 2012 Jul 20;6:49
pubmed: 22833718
Trends Cogn Sci. 2014 Apr;18(4):194-202
pubmed: 24581556
J Neurosci. 2014 Oct 15;34(42):14147-62
pubmed: 25319709
Nature. 2010 Jul 29;466(7306):622-6
pubmed: 20613723
Psychol Med. 2016 Aug;46(11):2263-74
pubmed: 27188979
Neuropsychopharmacology. 2020 Apr;45(5):780-785
pubmed: 31962344
J Neurosci. 2016 Sep 14;36(37):9516-25
pubmed: 27629704
Psychol Rev. 2014 Jul;121(3):337-66
pubmed: 25090423
J Neurosci. 2010 Jun 30;30(26):8888-96
pubmed: 20592211
Transl Psychiatry. 2016 Jul 05;6(7):e850
pubmed: 27378550
Neurosci Biobehav Rev. 2021 Jan;120:123-158
pubmed: 33202256
Trends Neurosci. 2015 Jun;38(6):345-52
pubmed: 25959611
J Neurosci. 2012 Jul 4;32(27):9402-9
pubmed: 22764248
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):11890-11895
pubmed: 29078303
Eur Neuropsychopharmacol. 2015 Jun;25(6):817-27
pubmed: 25840742
J Psychiatry Neurosci. 2013 Nov;38(6):388-97
pubmed: 23735584
Philos Trans R Soc Lond B Biol Sci. 2014 Nov 5;369(1655):
pubmed: 25267823
Curr Biol. 2015 Mar 30;25(7):912-9
pubmed: 25802148
Curr Opin Neurobiol. 2011 Apr;21(2):322-7
pubmed: 21333525
Personal Neurosci. 2020 Jun 23;3:e7
pubmed: 32656492
Front Integr Neurosci. 2018 Feb 13;12:6
pubmed: 29487508
Sci Rep. 2019 Apr 4;9(1):5652
pubmed: 30948756
Front Neurosci. 2012 Aug 10;6:116
pubmed: 22905023
Nat Neurosci. 2010 Apr;13(4):475-81
pubmed: 20208527
Neuropsychopharmacology. 2016 Oct;41(11):2658-67
pubmed: 27149935
Trends Neurosci. 2018 Aug;41(8):512-525
pubmed: 29747856
PLoS One. 2019 Dec 31;14(12):e0226893
pubmed: 31891605
J Neurosci. 2012 Sep 19;32(38):13032-8
pubmed: 22993421
Neuroscience. 1991;40(3):657-71
pubmed: 2062437
Neuron. 2010 Jun 24;66(6):896-907
pubmed: 20620875
PLoS One. 2008 Jun 25;3(6):e2479
pubmed: 18575579
Schizophr Bull. 2015 Mar;41(2):503-12
pubmed: 25053653
Psychol Sci. 2021 Nov;32(11):1842-1855
pubmed: 34705578
Curr Biol. 2014 Nov 3;24(21):2491-500
pubmed: 25283778
eNeuro. 2018 Apr 6;5(2):
pubmed: 29632870
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Nov;2(8):680-688
pubmed: 29560902
Brain. 1991 Feb;114 ( Pt 1B):513-25
pubmed: 2004254
Curr Biol. 2015 Jul 20;25(14):1852-9
pubmed: 26144968
Biol Psychiatry. 2020 Apr 1;87(7):678-685
pubmed: 31668477
J Exp Psychol Gen. 2016 Apr;145(4):389-96
pubmed: 26913619
Elife. 2020 Oct 13;9:
pubmed: 33046213
Nat Commun. 2017 Jul 11;8:15964
pubmed: 28696410
Psychopharmacology (Berl). 2007 Apr;191(3):507-20
pubmed: 17031711
Neurosci Biobehav Rev. 2012 Jan;36(1):64-78
pubmed: 21550365
Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):373-82
pubmed: 11509194
J Cogn Neurosci. 2013 Dec;25(12):2061-71
pubmed: 23937688
J Neurosci. 2015 Jul 8;35(27):9811-22
pubmed: 26156984
Neuropsychopharmacology. 2007 Aug;32(8):1678-86
pubmed: 17203013
Neuropsychopharmacology. 2018 May;43(6):1415-1424
pubmed: 29251282
Psychopharmacology (Berl). 2014 Jan;231(1):135-41
pubmed: 23900641
J Clin Psychopharmacol. 2008 Feb;28(1):45-51
pubmed: 18204340
Neuropsychopharmacology. 2002 Nov;27(5):813-25
pubmed: 12431855
Biol Psychiatry. 2012 Jul 15;72(2):107-12
pubmed: 22520343
Nature. 2019 Jun;570(7759):65-70
pubmed: 31118513
Science. 2020 Mar 20;367(6484):1362-1366
pubmed: 32193325
Nat Rev Neurosci. 2019 Nov;20(11):703-714
pubmed: 31570826
Exp Clin Psychopharmacol. 2008 Apr;16(2):113-23
pubmed: 18489015
Nature. 2016 Mar 31;531(7596):642-6
pubmed: 27007845
Psychol Med. 2020 Jul;50(10):1613-1622
pubmed: 31280757
J Neurosci. 2019 Jan 9;39(2):321-332
pubmed: 30446530
Psychol Rev. 2013 Apr;120(2):329-55
pubmed: 23586447
PLoS One. 2013 Jul 03;8(7):e68177
pubmed: 23844168
J Neurosci. 2020 Oct 7;40(41):7936-7948
pubmed: 32948675
Behav Brain Res. 2009 Jul 19;201(1):216-22
pubmed: 19428636
Science. 1997 Mar 14;275(5306):1593-9
pubmed: 9054347
Nat Hum Behav. 2017 Nov;1(11):819-827
pubmed: 31024122
Addiction. 2018 Dec;113(12):2173-2181
pubmed: 30047179
Soc Cogn Affect Neurosci. 2017 Feb 1;12(2):311-318
pubmed: 27677943
J Neurosci. 2008 Jan 30;28(5):1208-12
pubmed: 18234898
Front Neurosci. 2013 Apr 19;7:62
pubmed: 23626521
Neuron. 2012 Nov 8;76(3):470-85
pubmed: 23141060
Curr Opin Behav Sci. 2018 Aug;22:28-34
pubmed: 29713659

Auteurs

Alexander Soutschek (A)

Department of Psychology, Ludwig Maximilian University Munich, Munich, Germany.

Alexander Jetter (A)

Department of Clinical Pharmacology and Toxicology, University Hospital Zürich, University of Zürich, Zürich, Switzerland.

Philippe N Tobler (PN)

Zürich Center for Neuroeconomics, Department of Economics, University of Zürich, Zürich, Switzerland.
Neuroscience Center Zürich, Swiss Federal Institute of Technology Zürich, University of Zürich, Zürich, Switzerland.

Classifications MeSH